Applied Therapeutics Inc (NASDAQ:APLT) currently has a daily average trading volume of 6.38M but it saw 4786804 shares traded in last market. With a market cap of 72.19M USD, the company’s current market price of $0.62 came falling about -5.89 while comparing to the previous closing price of $0.66. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.62 and as low as $0.60. In the recent trading on the day, stock has struck highest price mark of $0.61 while lowest mark touched by it was $0.6687.
Taking a look at 20-day trading activity of Applied Therapeutics Inc (APLT) gives us an average price of $0.8371, while its current price level is -94.16% below from 52-week high level whereas it is 3.13% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.0540 while that of 200 days or SMA-200 reads an average of $5.3883. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.34% during that period while stretching the period over a month that decreases to 12.96%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 19.02 which implies that the stock is in oversold territory.
UBS downgraded its recommendation for the stock as a “Neutral” from “Buy” on December 02, 2024 while assigning a price target range of $13-$2. RBC Capital Mkts also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $12 and $4.
Over the week, APLT’s stock price is moving -14.49% down while it is -46.05% when we observe its performance for the past one month. Year-to-date it is -27.54% down and over the past year, the stock is showing a downside performance of -75.18%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of -0.19 while estimate for next year EPS is -1.42. In next quarter, company is expected to be making quarterly sales of $12.32M as analysts are expecting the sales for current fiscal year at $533.6k and seeing the company making $15.46M in sales next year. Moreover, analysts are in estimates of $100k for current-quarter revenue.
Currently, Applied Therapeutics Inc’s total number of outstanding shares is 116.36M with 5.80% of that held by the insiders while 106.67% of its common stock has been owned by the institutions. Stock’s beta reads 1.91. Stock has a price to book (P/B) ratio of 12.25.
